Literature DB >> 17245455

Recognition and treatment recommendations for generalized anxiety disorder and major depressive episode: a cross-sectional study among general practitioners in norway.

Ingrid Olssøn1, Arnstein Mykletun, Alv A Dahl.   

Abstract

OBJECTIVE: Undertreatment by general practitioners (GPs) of patients who have generalized anxiety disorder (GAD) and major depressive episodes (MDEs) is well known. Overtreatment by GPs of patients without these disorders has received little attention. The aim of this study was to estimate GPs' recommended overtreatment (recommendation of treatment to patients who, on the basis of diagnostic self-ratings, had neither GAD nor MDE) and undertreatment (not recommending treatment to patients who, on the basis of self-ratings, had GAD or MDE) and to describe patient variables associated with overtreatment.
METHOD: In a cross-sectional design (during 3 consecutive days in September 2001), 136 Norwegian GPs evaluated 1332 patients. Diagnostic reference standards were patients' ratings of validated DSM-IV criteria-based questionnaires. GPs identified somatic diseases and mental disorders according to all accumulated information. For their diagnoses of MDE and GAD, the Clinical Global Impressions-Severity of Illness scale was used as a supplement, and GPs suggested treatment for these disorders.
RESULTS: The GPs recommended overtreatment in 11% (132/1245) of cases. The rates of under-treatment were 64% (18/28) and 49% (23/47) for GAD and MDE, respectively. For comorbid GAD and MDE the rate of undertreatment was 17% (2/12). Mental reason for patient's current visit and poor self-rated subjective health were strongly associated with overtreatment.
CONCLUSION: Our preliminary study indicates that overtreatment by GPs of patients who, according to self-rating, do not have GAD or MDE could represent a problem. Criteria-based diagnostic descriptions might be of limited relevance for the practice of GPs, and the issue of overtreatment should be investigated further in studies with improved design.

Entities:  

Year:  2006        PMID: 17245455      PMCID: PMC1764523          DOI: 10.4088/pcc.v08n0604

Source DB:  PubMed          Journal:  Prim Care Companion J Clin Psychiatry        ISSN: 1523-5998


  26 in total

1.  Prevalence of and risk factors for lifetime suicide attempts in the National Comorbidity Survey.

Authors:  R C Kessler; G Borges; E E Walters
Journal:  Arch Gen Psychiatry       Date:  1999-07

Review 2.  Is general practice effective? A systematic literature review.

Authors:  S Engström; M Foldevi; L Borgquist
Journal:  Scand J Prim Health Care       Date:  2001-06       Impact factor: 2.581

3.  Detection of depression and anxiety in primary care: follow up study.

Authors:  David Kessler; Olive Bennewith; Glyn Lewis; Deborah Sharp
Journal:  BMJ       Date:  2002-11-02

4.  Accuracy of diagnosing depression in primary care: the impact of chronic somatic and psychiatric co-morbidity.

Authors:  Jasper Nuyen; Anita C Volkers; Peter F M Verhaak; François G Schellevis; Peter P Groenewegen; Geertrudis A M Van den Bos
Journal:  Psychol Med       Date:  2005-08       Impact factor: 7.723

5.  Generalized anxiety and depression in primary care: prevalence, recognition, and management.

Authors:  Hans-Ulrich Wittchen; Ron C Kessler; Katja Beesdo; Petra Krause; Michael Höfler; Jürgen Hoyer
Journal:  J Clin Psychiatry       Date:  2002       Impact factor: 4.384

6.  National trends in the outpatient treatment of depression.

Authors:  Mark Olfson; Steven C Marcus; Benjamin Druss; Lynn Elinson; Terri Tanielian; Harold Alan Pincus
Journal:  JAMA       Date:  2002-01-09       Impact factor: 56.272

7.  ["Generalized anxiety and depression in primary care" (GAD-P). Study design and methods].

Authors:  P Krause; H U Wittchen; M Höfler; S Winter; B Spiegel; H Pfister
Journal:  Fortschr Med Orig       Date:  2001

8.  Screening for anxiety disorders. Sensitivity and specificity of the Anxiety Screening Questionnaire (ASQ-15).

Authors:  H U Wittchen; P Boyer
Journal:  Br J Psychiatry Suppl       Date:  1998

9.  Concordance between symptom screening and diagnostic procedure: the Hopkins Symptom Checklist-25 and the Composite International Diagnostic Interview I.

Authors:  I Sandanger; T Moum; G Ingebrigtsen; O S Dalgard; T Sørensen; D Bruusgaard
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1998-07       Impact factor: 4.328

10.  General practitioner recognition of mental illness in the absence of a 'gold standard'.

Authors: 
Journal:  Aust N Z J Psychiatry       Date:  2004-10       Impact factor: 5.744

View more
  5 in total

1.  General practitioners' opinions on how to improve treatment of mental disorders in primary health care. Interviews with one hundred Norwegian general practitioners.

Authors:  Arnstein Mykletun; Ann Kristin Knudsen; Tone Tangen; Simon Overland
Journal:  BMC Health Serv Res       Date:  2010-02-09       Impact factor: 2.655

Review 2.  Atypical antipsychotics in primary generalized anxiety disorder or comorbid with mood disorders.

Authors:  Keming Gao; David V Sheehan; Joseph R Calabrese
Journal:  Expert Rev Neurother       Date:  2009-08       Impact factor: 4.618

3.  Patient factors associated with guideline-concordant treatment of anxiety and depression in primary care.

Authors:  Marijn A Prins; Peter F M Verhaak; Mirrian Smolders; Miranda G H Laurant; Klaas van der Meer; Peter Spreeuwenberg; Harm W J van Marwijk; Brenda W J H Penninx; Jozien M Bensing
Journal:  J Gen Intern Med       Date:  2010-01-05       Impact factor: 5.128

4.  Depressive symptoms in late life in urban and semi-urban areas of South-West Greece: An undetected disorder?

Authors:  Konstantinos Argyropoulos; Christos Bartsokas; Argyro Argyropoulou; Philippos Gourzis; Eleni Jelastopulu
Journal:  Indian J Psychiatry       Date:  2015 Jul-Sep       Impact factor: 1.759

5.  Generalized anxiety disorder in primary care: mental health services use and treatment adequacy.

Authors:  Pasquale Roberge; François Normand-Lauzière; Isabelle Raymond; Mireille Luc; Marie-Michèle Tanguay-Bernard; Arnaud Duhoux; Christian Bocti; Louise Fournier
Journal:  BMC Fam Pract       Date:  2015-10-22       Impact factor: 2.497

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.